Clinical Trial Update: Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate locoregional injections of ex vivo expanded natural killer cells in patients with high-grade glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Drugs mentioned

• Ex vivo expanded natural killer cells

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: High Grade Glioma | Phase 1 | Status: RECRUITING